Search research articles
Contact Us
Filters
Showing results (351-360 of 361) with videos related to
Page
of 37
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2013
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging
Lin-Quan Tang, Qiu-Yan Chen, Wei Fan, et al.
Nature Communications
|
March 31, 2026
Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trial
Li-Ting Liu, Xue-Song Sun, Ting-Ting Quan, et al.
NEJM Evidence
|
April 22, 2025
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal Carcinoma
Pei-Yu Huang, Xu-Yin Chen, Xi Ding, et al.
The Lancet. Oncology
|
June 8, 2023
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial
Li-Ting Liu, Huai Liu, Ying Huang, et al.
JAMA Oncology
|
March 24, 2022
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial
Wang-Zhong Li, Xing Lv, Dan Hu, et al.
Clinical Reviews in Allergy & Immunology
|
February 19, 2015
Multiple genetic variants associated with primary biliary cirrhosis in a Han Chinese population
Ming Dong, Jinxin Li, Ruqi Tang, et al.
Journal of Autoimmunity
|
December 8, 2019
Fine mapping of the MHC region identifies major independent variants associated with Han Chinese primary biliary cholangitis
Chan Wang, Xiaodong Zheng, Ruqi Tang, et al.
Hepatology (Baltimore, Md.)
|
March 12, 2019
Genome-wide Association Studies of Specific Antinuclear Autoantibody Subphenotypes in Primary Biliary Cholangitis
Chan Wang, Xiaodong Zheng, Peng Jiang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao
|
June 22, 2023
Differential regulation of JAK1 expression by ETS1 associated with predisposition to primary biliary cholangitis
Peng Jiang, Chan Wang, Mingming Zhang, et al.
The New England Journal of Medicine
|
March 19, 2020
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
Bin Cao, Yeming Wang, Danning Wen, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 361) with videos related to
Sort By:
Page
of 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2013
Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging
Lin-Quan Tang, Qiu-Yan Chen, Wei Fan, et al.
Nature Communications
|
March 31, 2026
Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trial
Li-Ting Liu, Xue-Song Sun, Ting-Ting Quan, et al.
NEJM Evidence
|
April 22, 2025
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal Carcinoma
Pei-Yu Huang, Xu-Yin Chen, Xi Ding, et al.
The Lancet. Oncology
|
June 8, 2023
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial
Li-Ting Liu, Huai Liu, Ying Huang, et al.
JAMA Oncology
|
March 24, 2022
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial
Wang-Zhong Li, Xing Lv, Dan Hu, et al.
Clinical Reviews in Allergy & Immunology
|
February 19, 2015
Multiple genetic variants associated with primary biliary cirrhosis in a Han Chinese population
Ming Dong, Jinxin Li, Ruqi Tang, et al.
Journal of Autoimmunity
|
December 8, 2019
Fine mapping of the MHC region identifies major independent variants associated with Han Chinese primary biliary cholangitis
Chan Wang, Xiaodong Zheng, Ruqi Tang, et al.
Hepatology (Baltimore, Md.)
|
March 12, 2019
Genome-wide Association Studies of Specific Antinuclear Autoantibody Subphenotypes in Primary Biliary Cholangitis
Chan Wang, Xiaodong Zheng, Peng Jiang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao
|
June 22, 2023
Differential regulation of JAK1 expression by ETS1 associated with predisposition to primary biliary cholangitis
Peng Jiang, Chan Wang, Mingming Zhang, et al.
The New England Journal of Medicine
|
March 19, 2020
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
Bin Cao, Yeming Wang, Danning Wen, et al.
Page
of 37